NEWS & PRESS RELEASES
Saturn TMVR System in Eurointervention
Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response...
Animation of the Saturn TMVR System Trans-septal Procedure
🎥 Watch our animation that showcases the trans-septal implant procedure of the Saturn TMVR system here. The Saturn device has a 29 French Valve Delivery System and 2 valve sizes (28 and 31mm) designed to anchor to the native mitral valve through a subannular ring at...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l. announces the closing of its Series C financing with granting an...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard